Cashu
Analyst Ratings Highlight Mixed Sentiment on WAVE Life Sciences' Future in Biotechnology
10 days ago
Stocks
Health Care
wve
Wave Life Sciences
WVE
+0.20 (+2.96%)
6.95
USD
At close at Jul 04, 20:41 UTC
Overview
Loading chart...
Key Stats
Market Cap
1.07B
Dividend Yield
0.00%
P/E Ratio
-9.50
EPS
-0.69
Revenue
108.30M
Avg. Volume
2.13M
About
What does WVE do?
Wave Life Sciences is a clinical-stage biotechnology company focused on RNA medicines, utilizing its PRISM platform to develop treatments for disorders like Duchenne muscular dystrophy and Huntington’s disease. Founded in 2015, it employs 266 people and is advancing RNA-targeting modalities such as editing and interference.
Join our newsletter to keep up to date with us!
